Yeah they do. John Hopkins results for MEB due to be released this month and should be a catalyst to push the SP much higher........FIL buying in big, both on market and as part of the recent placement.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
